169 related articles for article (PubMed ID: 18286553)
1. Targeted RNA interference of cyclin A2 mediated by functionalized single-walled carbon nanotubes induces proliferation arrest and apoptosis in chronic myelogenous leukemia K562 cells.
Wang X; Ren J; Qu X
ChemMedChem; 2008 Jun; 3(6):940-5. PubMed ID: 18286553
[TBL] [Abstract][Full Text] [Related]
2. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model.
Podesta JE; Al-Jamal KT; Herrero MA; Tian B; Ali-Boucetta H; Hegde V; Bianco A; Prato M; Kostarelos K
Small; 2009 May; 5(10):1176-85. PubMed ID: 19306454
[TBL] [Abstract][Full Text] [Related]
4. RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killing by 17-allylamino-17-demethoxygeldanamycin.
Withey JM; Harvey AJ; Crompton MR
Leuk Res; 2006 May; 30(5):553-60. PubMed ID: 16260034
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
Li R; Wu R; Zhao L; Wu M; Yang L; Zou H
ACS Nano; 2010 Mar; 4(3):1399-408. PubMed ID: 20148593
[TBL] [Abstract][Full Text] [Related]
6. [Knockdown of Hsp701A induces K562 cells apoptosis by RNA interference].
Zhu Q; Zhang WG; Wang LF; Wang F; Zhang Y; Yang AG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):480-2, 484. PubMed ID: 16806014
[TBL] [Abstract][Full Text] [Related]
7. Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells.
Shi L; Song Q; Zhang Y; Lou Y; Wang Y; Tian L; Zheng Y; Ma D; Ke X; Wang Y
Biochem Biophys Res Commun; 2010 May; 396(2):224-30. PubMed ID: 20398626
[TBL] [Abstract][Full Text] [Related]
8. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
9. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
10. Combination of SK-7041, one of novel histone deacetylase inhibitors, and STI571-induced synergistic apoptosis in chronic myeloid leukemia.
Kim BS; Bae E; Kim YJ; Ahn KS; Park J; Rhee JY; Lee YY; Kim Y; Lee D; Kim BK; Yoon SS
Anticancer Drugs; 2007 Jul; 18(6):641-7. PubMed ID: 17762392
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
12. A novel kind of nitrogen heterocycle compound induces apoptosis of human chronic myelogenous leukemia K562 cells.
Ding G; Liu F; Yang T; Jiang Y; Fu H; Zhao Y
Bioorg Med Chem; 2006 Jun; 14(11):3766-74. PubMed ID: 16466924
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
14. [Cyclin D2 expression in chronic myelogenous leukemia].
Song JM; Xu D; Fan EJ; Xu SR; Li D; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):103-5. PubMed ID: 14990053
[TBL] [Abstract][Full Text] [Related]
15. Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells.
Lavallard VJ; Pradelli LA; Paul A; Bénéteau M; Jacquel A; Auberger P; Ricci JE
Cancer Res; 2009 Apr; 69(7):3013-20. PubMed ID: 19318579
[TBL] [Abstract][Full Text] [Related]
16. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma.
Li K; Lin SY; Brunicardi FC; Seu P
Cancer Res; 2003 Jul; 63(13):3593-7. PubMed ID: 12839946
[TBL] [Abstract][Full Text] [Related]
17. Functionalization of carbon nanotubes enables non-covalent binding and intracellular delivery of small interfering RNA for efficient knock-down of genes.
Krajcik R; Jung A; Hirsch A; Neuhuber W; Zolk O
Biochem Biophys Res Commun; 2008 May; 369(2):595-602. PubMed ID: 18298946
[TBL] [Abstract][Full Text] [Related]
18. MEKC-LIF analysis of rhodamine123 delivered by carbon nanotubes in K562 cells.
Li R; Wu R; Wu M; Zou H; Ma H; Yang L; Le XC
Electrophoresis; 2009 Jun; 30(11):1906-12. PubMed ID: 19522016
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SS18-SSX1 expression by small interfering RNA inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro.
Peng C; Guo W; Yang Y; Zhao H
Eur J Cancer Prev; 2008 Oct; 17(5):392-8. PubMed ID: 18714179
[TBL] [Abstract][Full Text] [Related]
20. [Effect of hexamethylene bisacetamine on proliferation and apoptosis of human leukemia cells in vitro and relevant mechanisms].
Yu H; Lu H; Zheng B; Fan H; Xie Y
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):549-52. PubMed ID: 12133503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
